FindTrial
Sign In

To see role of REG 1 alpha as a marker for adherance to Gluten free diet in Celiac Disease

Serum Regenerating gene 1 alpha as a biomarker for Celiac Disease activity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/033183
Enrollment
40
Registered
2021-04-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K900- Celiac disease

Interventions

None listed

Sponsors

Department of Pediatrics Maulana Azad Medical College and Associated Lok Nayak Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly suspected Celiac Disease presenting to Dept of Pediatrics Diagnosis as per as ESPGHAN 2020 criteria

Exclusion criteria

Exclusion criteria: Patients with known Chronic Inflammatory bowel disease and history of necrotizing enterocolitis and known short bowel syndrome and chronic arthritis autoinflammatory or rheumatologic or systemic vasculitis disorders and known chronic kidney disease and patients on systemic corticosteroids and other immunosuppressants

Design outcomes

Primary

MeasureTime frame
Change in the levels of Reg 1 alpha levels after 3 months of the institution of Gluten free dietTimepoint: 1 year—

Secondary

MeasureTime frame
The correlation between serum regenerating gene 1 alpha levels with antitissue transglutaminase immunoglobin A levels and modified Marsh grading in children with Celiac DiseaseTimepoint: 1 year—

Countries

India

Contacts

Public ContactDr Versha Raj

Maulana Azad Medical College and Associated Lok Nayak Hospital

drseemakapoor@gmail.com9868846606

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026